Live tape
Top 8, mentions 7d10,503TSLA2,131 mentions▲ +0.05GOOGL1,646 mentions▲ +0.04CRWV1,305 mentions▲ +0.03NVDA1,270 mentions▲ +0.07SPCX1,163 mentions▲ +0.07QQQ1,138 mentions▲ +0.05META941 mentions▲ +0.05NBIS909 mentions▲ +0.05

Equity · Healthcare

AGIO

NASDAQ

Agios Pharmaceuticals, Inc.

$31.36 −2.00% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$37.5 $27.5 21 Jul 16 Oct

The line runs $37.34 on 21 July through $31.36 on 16 October, on a scale from $27.5 to $37.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
Market cap $1.9B
52-week range $23 – $45.46
Avg volume 56.3K

as of Oct 16, 2026

AGIO insider trades

SEC Form 4 · last 90 days · newest reported trade 4 Aug 2026
Open-market buys 0
Open-market sells 1
Net sold $914K
Non-trade filings 0
Date Insider Type Shares Value
04 Aug 2026 Gheuens Sarah Chief Medical Officer Sell 30,000 $914K

AGIO reported financials

SEC EDGAR XBRL SEC EDGAR

AGIO reported revenue of $54.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$412.8M.

Figure Reported Period
Revenue $54.0M 31 Dec 2025 fiscal year
Net income −$412.8M 31 Dec 2025 fiscal year
Diluted EPS −$7.12 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $1.0B 30 Jun 2026 at period end

AGIO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.69 —
31 Mar 2026 Q1 2026 −$1.69 —
31 Dec 2025 FY 2025 −$7.12 —
30 Sep 2025 Q3 2025 −$1.78 —
30 Jun 2025 Q2 2025 −$1.93 —
31 Mar 2025 Q1 2025 −$1.55 —
31 Dec 2024 FY 2024 $11.64 —
30 Sep 2024 Q3 2024 $16.22 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AGIO institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a AGIO position for the quarter ended 30 Jun 2026 — a combined $218.8M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) +15.9% shares 3,107,005 $115.3M
Citadel Advisors Held (±25%) +18.2% shares 732,687 $27.2M
AQR Capital Management Added +1,779.5% shares 684,340 $25.4M
Two Sigma Investments Added +113.2% shares 536,380 $19.9M
Point72 Asset Management New position 506,344 $18.8M
Marshall Wace Trimmed −69.0% shares 138,800 $5.2M
Man Group Held (±25%) −13.7% shares 124,466 $4.6M
Tudor Investment Corp Held (±25%) +13.1% shares 65,779 $2.4M
Balyasny Asset Management Exited
Millennium Management Exited

Congressional trades in AGIO

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in AGIO is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 20 Aug 2026.

Date Member Type Amount
20 Aug 2026 filed 10 Sep 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
03 Mar 2026 filed 07 Apr 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
17 Apr 2025 filed 06 May 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
29 Jan 2025 filed 11 Feb 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
24 Jan 2024 filed 15 Feb 2024 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SEC EDGARValuation computed from SEC EDGAR filings